Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Alzheimer's Disease

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 207 articles:
HTML format



Single Articles


    January 2022
  1. KIM HJ, Ryou JH, Choi KT, Kim SM, et al
    Deficits in color detection in patients with Alzheimer disease.
    PLoS One. 2022;17:e0262226.
    PubMed     Abstract available


  2. SHABBIR U, Tyagi A, Ham HJ, Oh DH, et al
    Comprehensive profiling of bioactive compounds in germinated black soybeans via UHPLC-ESI-QTOF-MS/MS and their anti-Alzheimer's activity.
    PLoS One. 2022;17:e0263274.
    PubMed     Abstract available


  3. LEACH JM, Edwards LJ, Kana R, Visscher K, et al
    The spike-and-slab elastic net as a classification tool in Alzheimer's disease.
    PLoS One. 2022;17:e0262367.
    PubMed     Abstract available


  4. JUNG NY, Kim HS, Kim ES, Jeon S, et al
    Serum progranulin is not associated with rs5848 polymorphism in Korean patients with neurodegenerative diseases.
    PLoS One. 2022;17:e0261007.
    PubMed     Abstract available


  5. HUANG YC, Hsu SM, Shie FS, Shiao YJ, et al
    Reduced mitochondria membrane potential and lysosomal acidification are associated with decreased oligomeric Abeta degradation induced by hyperglycemia: A study of mixed glia cultures.
    PLoS One. 2022;17:e0260966.
    PubMed     Abstract available


  6. QUERFURTH H, Marshall J, Parang K, Rioult-Pedotti MS, et al
    A PDK-1 allosteric agonist neutralizes insulin signaling derangements and beta-amyloid toxicity in neuronal cells and in vitro.
    PLoS One. 2022;17:e0261696.
    PubMed     Abstract available


  7. LEE JI, Lim JS, Hong JH, Kim S, et al
    Selective neurodegeneration of the hippocampus caused by chronic cerebral hypoperfusion: F-18 FDG PET study in rats.
    PLoS One. 2022;17:e0262224.
    PubMed     Abstract available


  8. SADLEIR KR, Popovic J, Khatri A, Vassar R, et al
    Oral nimodipine treatment has no effect on amyloid pathology or neuritic dystrophy in the 5XFAD mouse model of amyloidosis.
    PLoS One. 2022;17:e0263332.
    PubMed     Abstract available


  9. REHMAN S, Ali Ashfaq U, Sufyan M, Shahid I, et al
    The Insight of In Silico and In Vitro evaluation of Beta vulgaris phytochemicals against Alzheimer's disease targeting acetylcholinesterase.
    PLoS One. 2022;17:e0264074.
    PubMed     Abstract available


  10. SUZUKI Y, Suzuki M, Shigenobu K, Shinosaki K, et al
    A prospective multicenter validation study of a machine learning algorithm classifier on quantitative electroencephalogram for differentiating between dementia with Lewy bodies and Alzheimer's dementia.
    PLoS One. 2022;17:e0265484.
    PubMed     Abstract available


  11. ZHANG Q, Yang X, Sun Z
    Classification of Alzheimer's disease progression based on sMRI using gray matter volume and lateralization index.
    PLoS One. 2022;17:e0262722.
    PubMed     Abstract available


  12. MARTIZ RM, Patil SM, Ramu R, M K J, et al
    Discovery of novel benzophenone integrated derivatives as anti-Alzheimer's agents targeting presenilin-1 and presenilin-2 inhibition: A computational approach.
    PLoS One. 2022;17:e0265022.
    PubMed     Abstract available


  13. PAYNE M, Manera V, Robert P, Vandersteen C, et al
    Olfactory identification disorders due to Alzheimer's disease: A new test from France to Quebec.
    PLoS One. 2022;17:e0265764.
    PubMed     Abstract available


  14. IOHAN LDCC, Lambert JC, Costa MR
    Analysis of modular gene co-expression networks reveals molecular pathways underlying Alzheimer's disease and progressive supranuclear palsy.
    PLoS One. 2022;17:e0266405.
    PubMed     Abstract available


  15. SARIS IMJ, Aghajani M, Jongs N, Reus LM, et al
    Cross-disorder and disorder-specific deficits in social functioning among schizophrenia and alzheimer's disease patients.
    PLoS One. 2022;17:e0263769.
    PubMed     Abstract available


  16. MOUSA D, Zayed N, Yassine IA
    Alzheimer disease stages identification based on correlation transfer function system using resting-state functional magnetic resonance imaging.
    PLoS One. 2022;17:e0264710.
    PubMed     Abstract available


  17. KORTHAUER LE, Giugliano RP, Guo J, Sabatine MS, et al
    No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumab.
    PLoS One. 2022;17:e0266615.
    PubMed     Abstract available


  18. YOUSEFZADEH-NOWSHAHR E, Winter G, Bohn P, Kneer K, et al
    Quantitative analysis of regional distribution of tau pathology with 11C-PBB3-PET in a clinical setting.
    PLoS One. 2022;17:e0266906.
    PubMed     Abstract available


  19. UCHIYAMA S, Kamoi F, Tanaka M, Joko I, et al
    What is the subtype of dementia in patients with fragility hip fracture?
    PLoS One. 2022;17:e0265636.
    PubMed     Abstract available


  20. ABD EL-RAHMAN SS, Fayed HM
    Improved cognition impairment by activating cannabinoid receptor type 2: Modulating CREB/BDNF expression and impeding TLR-4/NFkappaBp65/M1 microglia signaling pathway in D-galactose-injected ovariectomized rats.
    PLoS One. 2022;17:e0265961.
    PubMed     Abstract available


  21. SOLIMAN MG, Davies HA, Sharkey J, Levy R, et al
    Development of amyloid beta gold nanorod aggregates as optoacoustic probes.
    PLoS One. 2022;17:e0259608.
    PubMed     Abstract available


  22. BANACK SA, Stark AC, Cox PA
    A possible blood plasma biomarker for early-stage Alzheimer's disease.
    PLoS One. 2022;17:e0267407.
    PubMed     Abstract available


  23. NAITO N, Hirosawa T, Tsubomoto M, Miyagishi Y, et al
    Prominent gamma band activity during visual motion perception in early-stage Alzheimer's disease.
    PLoS One. 2022;17:e0266693.
    PubMed     Abstract available


  24. SOUDY R, Kimura R, Fu W, Patel A, et al
    Extracellular vesicles enriched with amylin receptor are cytoprotective against the Ass toxicity in vitro.
    PLoS One. 2022;17:e0267164.
    PubMed     Abstract available


  25. HERNANDEZ M, Ramon-Julvez U, Ferraz F
    Explainable AI toward understanding the performance of the top three TADPOLE Challenge methods in the forecast of Alzheimer's disease diagnosis.
    PLoS One. 2022;17:e0264695.
    PubMed     Abstract available


  26. PHAM H, Yin T, D'Adamio L
    Initial assessment of the spatial learning, reversal, and sequencing task capabilities of knock-in rats with humanizing mutations in the Abeta-coding region of App.
    PLoS One. 2022;17:e0263546.
    PubMed     Abstract available


  27. ANDRADE JM, Pachar P, Trujillo L, Cartuche L, et al
    Suillin: A mixed-type acetylcholinesterase inhibitor from Suillus luteus which is used by Saraguros indigenous, southern Ecuador.
    PLoS One. 2022;17:e0268292.
    PubMed     Abstract available


  28. CANNAVO C, Cleverley K, Maduro C, Mumford P, et al
    Endosomal structure and APP biology are not altered in a preclinical mouse cellular model of Down syndrome.
    PLoS One. 2022;17:e0262558.
    PubMed     Abstract available


  29. ALI M, Sung YJ, Wang F, Fernandez MV, et al
    Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of Klotho heterozygosity on disease risk.
    PLoS One. 2022;17:e0267298.
    PubMed     Abstract available


  30. GARCIA MARIN ID, Camarillo Lopez RH, Martinez OA, Padilla-Martinez II, et al
    New compounds from heterocyclic amines scaffold with multitarget inhibitory activity on Abeta aggregation, AChE, and BACE1 in the Alzheimer disease.
    PLoS One. 2022;17:e0269129.
    PubMed     Abstract available


  31. SELF W, Awwad K, Savaryn JP, Schulz M, et al
    An immuno-enrichment free, validated quantification of tau protein in human CSF by LC-MS/MS.
    PLoS One. 2022;17:e0269157.
    PubMed     Abstract available


  32. ZAMANI J, Sadr A, Javadi AH
    Classification of early-MCI patients from healthy controls using evolutionary optimization of graph measures of resting-state fMRI, for the Alzheimer's disease neuroimaging initiative.
    PLoS One. 2022;17:e0267608.
    PubMed     Abstract available


  33. LEE H, Kim HK, Kim B, Han K, et al
    Augmented risk of dementia in hypertrophic cardiomyopathy: A propensity score matching analysis using the nationwide cohort.
    PLoS One. 2022;17:e0269911.
    PubMed     Abstract available


    January 2021
  34. PENNER G, Lecocq S, Chopin A, Vedoya X, et al
    Aptamarker prediction of brain amyloid-beta status in cognitively normal individuals at risk for Alzheimer's disease.
    PLoS One. 2021;16:e0243902.
    PubMed     Abstract available


  35. VIDONI ED, Morris JK, Watts A, Perry M, et al
    Effect of aerobic exercise on amyloid accumulation in preclinical Alzheimer's: A 1-year randomized controlled trial.
    PLoS One. 2021;16:e0244893.
    PubMed     Abstract available


  36. MEGHDADI AH, Stevanovic Karic M, McConnell M, Rupp G, et al
    Resting state EEG biomarkers of cognitive decline associated with Alzheimer's disease and mild cognitive impairment.
    PLoS One. 2021;16:e0244180.
    PubMed     Abstract available


  37. TOKUMITSU K, Yasui-Furukori N, Takeuchi J, Yachimori K, et al
    The combination of MMSE with VSRAD and eZIS has greater accuracy for discriminating mild cognitive impairment from early Alzheimer's disease than MMSE alone.
    PLoS One. 2021;16:e0247427.
    PubMed     Abstract available


  38. CHELLAPPA RC, Lukose B, Rani P
    Correction: G82S RAGE polymorphism influences amyloid-RAGE interactions relevant in Alzheimer's disease pathology.
    PLoS One. 2021;16:e0248252.
    PubMed     Abstract available


  39. VOIGT RM, Raeisi S, Yang J, Leurgans S, et al
    Systemic brain derived neurotrophic factor but not intestinal barrier integrity is associated with cognitive decline and incident Alzheimer's disease.
    PLoS One. 2021;16:e0240342.
    PubMed     Abstract available


  40. GJERUM L, Andersen BB, Bruun M, Simonsen AH, et al
    Comparison of the clinical impact of 2-[18F]FDG-PET and cerebrospinal fluid biomarkers in patients suspected of Alzheimer's disease.
    PLoS One. 2021;16:e0248413.
    PubMed     Abstract available


  41. ZABEL P, Kaluzny JJ, Zabel K, Kaluzna M, et al
    Quantitative assessment of retinal thickness and vessel density using optical coherence tomography angiography in patients with Alzheimer's disease and glaucoma.
    PLoS One. 2021;16:e0248284.
    PubMed     Abstract available


  42. BAHADO-SINGH RO, Vishweswaraiah S, Aydas B, Yilmaz A, et al
    Artificial intelligence and leukocyte epigenomics: Evaluation and prediction of late-onset Alzheimer's disease.
    PLoS One. 2021;16:e0248375.
    PubMed     Abstract available


  43. KIM D, Lee JH, Kim HY, Shin J, et al
    Correction: Fluorescent indolizine derivative YI-13 detects amyloid-beta monomers, dimers, and plaques in the brain of 5XFAD Alzheimer transgenic mouse model.
    PLoS One. 2021;16:e0250194.
    PubMed     Abstract available


  44. TSUNEISHI M, Yamamoto T, Yamaguchi T, Kodama T, et al
    Association between number of teeth and Alzheimer's disease using the National Database of Health Insurance Claims and Specific Health Checkups of Japan.
    PLoS One. 2021;16:e0251056.
    PubMed     Abstract available


  45. VELAZQUEZ M, Lee Y
    Random forest model for feature-based Alzheimer's disease conversion prediction from early mild cognitive impairment subjects.
    PLoS One. 2021;16:e0244773.
    PubMed     Abstract available


  46. MCCORMICK JW, Ammerman L, Chen G, Vogel PD, et al
    Transport of Alzheimer's associated amyloid-beta catalyzed by P-glycoprotein.
    PLoS One. 2021;16:e0250371.
    PubMed     Abstract available


  47. WEN LY, Wan L, Lai JN, Chen CS, et al
    Increased risk of Alzheimer's disease among patients with age-related macular degeneration: A nationwide population-based study.
    PLoS One. 2021;16:e0250440.
    PubMed     Abstract available


  48. STOJANOVIC F, Taktek M, Khieu NH, Huang J, et al
    NMR analysis of the correlation of metabolic changes in blood and cerebrospinal fluid in Alzheimer model male and female mice.
    PLoS One. 2021;16:e0250568.
    PubMed     Abstract available


  49. ZHENG C, Xu R
    Molecular subtyping of Alzheimer's disease with consensus non-negative matrix factorization.
    PLoS One. 2021;16:e0250278.
    PubMed     Abstract available


  50. JIANG X, Howard JH Jr, Rebeck GW, Turner RS, et al
    Spatial inhibition of return is impaired in mild cognitive impairment and mild Alzheimer's disease.
    PLoS One. 2021;16:e0252958.
    PubMed     Abstract available


  51. ZHANG J, Zhang Y, Zou J, Cao F, et al
    A meta-analysis of cohort studies: Traumatic brain injury and risk of Alzheimer's Disease.
    PLoS One. 2021;16:e0253206.
    PubMed     Abstract available


  52. FUKUI K, Kimura S, Kato Y, Kohno M, et al
    Effects of far infrared light on Alzheimer's disease-transgenic mice.
    PLoS One. 2021;16:e0253320.
    PubMed     Abstract available


  53. WENG J, Zhao G, Weng L, Guan J, et al
    Aspirin using was associated with slower cognitive decline in patients with Alzheimer's disease.
    PLoS One. 2021;16:e0252969.
    PubMed     Abstract available


  54. MINICUCCI J, Alfond M, Demuro A, Gerberry D, et al
    Quantifying the dose-dependent impact of intracellular amyloid beta in a mathematical model of calcium regulation in xenopus oocyte.
    PLoS One. 2021;16:e0246116.
    PubMed     Abstract available


  55. TOPPING M, Kim J, Fletcher J
    Geographic variation in Alzheimer's disease mortality.
    PLoS One. 2021;16:e0254174.
    PubMed     Abstract available


  56. RHEW SH, Kravchenko J, Lyerly HK
    Exposure to low-dose ambient fine particulate matter PM2.5 and Alzheimer's disease, non-Alzheimer's dementia, and Parkinson's disease in North Carolina.
    PLoS One. 2021;16:e0253253.
    PubMed     Abstract available


  57. LIBOWITZ MR, Wei K, Tran T, Chu K, et al
    Regional brain volumes relate to Alzheimer's disease cerebrospinal fluid biomarkers and neuropsychometry: A cross-sectional, observational study.
    PLoS One. 2021;16:e0254332.
    PubMed     Abstract available


  58. HUI J, Zhao Y, Yu S, Liu J, et al
    Detection of retinal changes with optical coherence tomography angiography in mild cognitive impairment and Alzheimer's disease patients: A meta-analysis.
    PLoS One. 2021;16:e0255362.
    PubMed     Abstract available


  59. LEE SH, Chen YH, Chien CC, Yan YH, et al
    Three month inhalation exposure to low-level PM2.5 induced brain toxicity in an Alzheimer's disease mouse model.
    PLoS One. 2021;16:e0254587.
    PubMed     Abstract available


  60. SAKUTA S, Hashimoto M, Ikeda M, Koyama A, et al
    Clinical features of behavioral symptoms in patients with semantic dementia: Does semantic dementia cause autistic traits?
    PLoS One. 2021;16:e0247184.
    PubMed     Abstract available


  61. PIERSSON AD, Ibrahim B, Suppiah S, Mohamad M, et al
    Multiparametric MRI for the improved diagnostic accuracy of Alzheimer's disease and mild cognitive impairment: Research protocol of a case-control study design.
    PLoS One. 2021;16:e0252883.
    PubMed     Abstract available


  62. WICKLAND DP, Ren Y, Sinnwell JP, Reddy JS, et al
    Impact of variant-level batch effects on identification of genetic risk factors in large sequencing studies.
    PLoS One. 2021;16:e0249305.
    PubMed     Abstract available


  63. VESPA A, Spatuzzi R, Fabbietti P, Penna M, et al
    Association between care burden, depression and personality traits in Alzheimer's caregiver: A pilot study.
    PLoS One. 2021;16:e0251813.
    PubMed     Abstract available


  64. BARTL M, Dakna M, Galasko D, Hutten SJ, et al
    Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's disease.
    PLoS One. 2021;16:e0257372.
    PubMed     Abstract available


  65. KOLINGER GD, Vallez Garcia D, Willemsen ATM, Reesink FE, et al
    Amyloid burden quantification depends on PET and MR image processing methodology.
    PLoS One. 2021;16:e0248122.
    PubMed     Abstract available


  66. FERNANDEZ-BLAZQUEZ MA, Del Ser T, Frades-Payo B, Avila-Villanueva M, et al
    MADRID+90 study on factors associated with longevity: Study design and preliminary data.
    PLoS One. 2021;16:e0251796.
    PubMed     Abstract available


  67. CALDERON C, Beyle C, Veliz-Garcia O, Bekios-Calfa J, et al
    Psychometric properties of Addenbrooke's Cognitive Examination III (ACE-III): An item response theory approach.
    PLoS One. 2021;16:e0251137.
    PubMed     Abstract available


  68. AKBOR MM, Kurosawa N, Nakayama H, Nakatani A, et al
    Polymorphic SERPINA3 prolongs oligomeric state of amyloid beta.
    PLoS One. 2021;16:e0248027.
    PubMed     Abstract available


  69. PARWEEN F, Hossain MS, Singh KP, Gupta RD, et al
    Association between human paraoxonase 2 protein and efficacy of acetylcholinesterase inhibiting drugs used against Alzheimer's disease.
    PLoS One. 2021;16:e0258879.
    PubMed     Abstract available


  70. NOGUCHI-SHINOHARA M, Koike M, Morise H, Kudo K, et al
    MEG activity of the dorsolateral prefrontal cortex during optic flow stimulations detects mild cognitive impairment due to Alzheimer's disease.
    PLoS One. 2021;16:e0259677.
    PubMed     Abstract available


  71. BAILEY DK, Clark W, Kosman DJ
    The iron chelator, PBT434, modulates transcellular iron trafficking in brain microvascular endothelial cells.
    PLoS One. 2021;16:e0254794.
    PubMed     Abstract available


  72. WU Y, Whittaker HT, Noy S, Cleverley K, et al
    The effects of Cstb duplication on APP/amyloid-beta pathology and cathepsin B activity in a mouse model.
    PLoS One. 2021;16:e0242236.
    PubMed     Abstract available


  73. JIANG H, Esparza TJ, Kummer TT, Brody DL, et al
    Unbiased high-content screening reveals Abeta- and tau-independent synaptotoxic activities in human brain homogenates from Alzheimer's patients and high-pathology controls.
    PLoS One. 2021;16:e0259335.
    PubMed     Abstract available


  74. JIANG J, Liu H, Wang Z, Tian H, et al
    Electroacupuncture could balance the gut microbiota and improve the learning and memory abilities of Alzheimer's disease animal model.
    PLoS One. 2021;16:e0259530.
    PubMed     Abstract available


  75. CZAPSKI GA, Cieslik M, Bialopiotrowicz E, Lukiw WJ, et al
    Down-regulation of cyclin D2 in amyloid beta toxicity, inflammation, and Alzheimer's disease.
    PLoS One. 2021;16:e0259740.
    PubMed     Abstract available


  76. GRUNDMAN J, Spencer B, Sarsoza F, Rissman RA, et al
    Transcriptome analyses reveal tau isoform-driven changes in transposable element and gene expression.
    PLoS One. 2021;16:e0251611.
    PubMed     Abstract available


  77. WU X, Peng C, Nelson PT, Cheng Q, et al
    Random forest-integrated analysis in AD and LATE brain transcriptome-wide data to identify disease-specific gene expression.
    PLoS One. 2021;16:e0256648.
    PubMed     Abstract available


  78. SHIMODA A, Li Y, Hayashi H, Kondo N, et al
    Dementia risks identified by vocal features via telephone conversations: A novel machine learning prediction model.
    PLoS One. 2021;16:e0253988.
    PubMed     Abstract available


  79. XIN XY, Lai ZH, Ding KQ, Zeng LL, et al
    Angiotensin-converting enzyme polymorphisms AND Alzheimer's disease susceptibility: An updated meta-analysis.
    PLoS One. 2021;16:e0260498.
    PubMed     Abstract available


  80. HIRALDO-GONZALEZ L, Trillo-Contreras JL, Garcia-Miranda P, Pineda-Sanchez R, et al
    Evaluation of aquaporins in the cerebrospinal fluid in patients with idiopathic normal pressure hydrocephalus.
    PLoS One. 2021;16:e0258165.
    PubMed     Abstract available


  81. RICHARD P, Kozlowski L, Guillorit H, Garnier P, et al
    Queuine, a bacterial-derived hypermodified nucleobase, shows protection in in vitro models of neurodegeneration.
    PLoS One. 2021;16:e0253216.
    PubMed     Abstract available


  82. SCHOBER J, Polina J, Walters F, Scott N, et al
    NNC 26-9100 increases Abeta1-42 phagocytosis, inhibits nitric oxide production and decreases calcium in BV2 microglia cells.
    PLoS One. 2021;16:e0254242.
    PubMed     Abstract available


  83. KAMAL S, Park I, Kim YJ, Kim YJ, et al
    Alteration of the corpus callosum in patients with Alzheimer's disease: Deep learning-based assessment.
    PLoS One. 2021;16:e0259051.
    PubMed     Abstract available


  84. ZUELKE AE, Riedel-Heller SG, Wittmann F, Pabst A, et al
    Gender-specific design and effectiveness of non-pharmacological interventions against cognitive decline and dementia-protocol for a systematic review and meta-analysis.
    PLoS One. 2021;16:e0256826.
    PubMed     Abstract available


  85. KAYA-TILKI E, Dikmen M
    Neuroprotective effects of some epigenetic modifying drugs' on Chlamydia pneumoniae-induced neuroinflammation: A novel model.
    PLoS One. 2021;16:e0260633.
    PubMed     Abstract available


    January 2020
  86. KWAK DE, Ko T, Koh HS, Ji YW, et al
    Alterations of aqueous humor Abeta levels in Abeta-infused and transgenic mouse models of Alzheimer disease.
    PLoS One. 2020;15:e0227618.
    PubMed     Abstract available


  87. WESTMAN G, Schoofs C, Ingelsson M, Jarhult JD, et al
    Torque teno virus viral load is related to age, CMV infection and HLA type but not to Alzheimer's disease.
    PLoS One. 2020;15:e0227670.
    PubMed     Abstract available


  88. HAIDER S, Liaquat L, Ahmad S, Batool Z, et al
    Naringenin protects AlCl3/D-galactose induced neurotoxicity in rat model of AD via attenuation of acetylcholinesterase levels and inhibition of oxidative stress.
    PLoS One. 2020;15:e0227631.
    PubMed     Abstract available


  89. DOWNER B, Al Snih S, Raji M, Chou LN, et al
    Healthcare utilization of Mexican-American Medicare beneficiaries with and without Alzheimer's disease and related dementias.
    PLoS One. 2020;15:e0227681.
    PubMed     Abstract available


  90. BLOCH K, Hornfeld SH, Dar S, Vanichkin A, et al
    Long-term effects of intracranial islet grafting on cognitive functioning in a rat metabolic model of sporadic Alzheimer's disease-like dementia.
    PLoS One. 2020;15:e0227879.
    PubMed     Abstract available


  91. MAO Y, Fisher DW, Yang S, Keszycki RM, et al
    Protein-protein interactions underlying the behavioral and psychological symptoms of dementia (BPSD) and Alzheimer's disease.
    PLoS One. 2020;15:e0226021.
    PubMed     Abstract available


  92. LIAO JY, Lee CT, Lin TY, Liu CM, et al
    Exploring prior diseases associated with incident late-onset Alzheimer's disease dementia.
    PLoS One. 2020;15:e0228172.
    PubMed     Abstract available


  93. SUN YQ, Richmond RC, Chen Y, Mai XM, et al
    Mixed evidence for the relationship between periodontitis and Alzheimer's disease: A bidirectional Mendelian randomization study.
    PLoS One. 2020;15:e0228206.
    PubMed     Abstract available


  94. LEE EG, Tulloch J, Chen S, Leong L, et al
    Redefining transcriptional regulation of the APOE gene and its association with Alzheimer's disease.
    PLoS One. 2020;15:e0227667.
    PubMed     Abstract available


  95. OH AJ, Amore G, Sultan W, Asanad S, et al
    Correction: Pupillometry evaluation of melanopsin retinal ganglion cell function and sleep-wake activity in pre-symptomatic Alzheimer's disease.
    PLoS One. 2020;15:e0230061.
    PubMed     Abstract available


  96. WANG G, Kennedy RE, Goldberg TE, Fowler ME, et al
    Using practice effects for targeted trials or sub-group analysis in Alzheimer's disease: How practice effects predict change over time.
    PLoS One. 2020;15:e0228064.
    PubMed     Abstract available


  97. ORIMAYE SO, Goodkin K, Riaz OA, Salcedo JM, et al
    A machine learning-based linguistic battery for diagnosing mild cognitive impairment due to Alzheimer's disease.
    PLoS One. 2020;15:e0229460.
    PubMed     Abstract available


  98. BARTHOLD D, Joyce G, Diaz Brinton R, Wharton W, et al
    Association of combination statin and antihypertensive therapy with reduced Alzheimer's disease and related dementia risk.
    PLoS One. 2020;15:e0229541.
    PubMed     Abstract available


  99. LI X, Yang X, Sun Z
    Alpha rhythm slowing in a modified thalamo-cortico-thalamic model related with Alzheimer's disease.
    PLoS One. 2020;15:e0229950.
    PubMed     Abstract available


  100. MARZBAN EN, Eldeib AM, Yassine IA, Kadah YM, et al
    Alzheimer's disease diagnosis from diffusion tensor images using convolutional neural networks.
    PLoS One. 2020;15:e0230409.
    PubMed     Abstract available


  101. ZHOU M, Xu R, Kaelber DC, Gurney ME, et al
    Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer's disease in patients with rheumatoid arthritis and psoriasis.
    PLoS One. 2020;15:e0229819.
    PubMed     Abstract available


  102. SHANG Y, Mishra A, Wang T, Wang Y, et al
    Evidence in support of chromosomal sex influencing plasma based metabolome vs APOE genotype influencing brain metabolome profile in humanized APOE male and female mice.
    PLoS One. 2020;15:e0225392.
    PubMed     Abstract available


  103. IMAI H, Hirai T, Kumazawa R, Nakagawa S, et al
    Prevalence of and risk factors for adverse events in Alzheimer's patients receiving anti-dementia drugs in at-home care.
    PLoS One. 2020;15:e0231226.
    PubMed     Abstract available


  104. RHODIUS-MEESTER HFM, van Maurik IS, Koikkalainen J, Tolonen A, et al
    Selection of memory clinic patients for CSF biomarker assessment can be restricted to a quarter of cases by using computerized decision support, without compromising diagnostic accuracy.
    PLoS One. 2020;15:e0226784.
    PubMed     Abstract available


  105. CASTOR KJ, Shenoi S, Edminster SP, Tran T, et al
    Urine dicarboxylic acids change in pre-symptomatic Alzheimer's disease and reflect loss of energy capacity and hippocampal volume.
    PLoS One. 2020;15:e0231765.
    PubMed     Abstract available


  106. MOLINA M, Carmona I, Fuentes LJ, Plaza V, et al
    Enhanced learning and retention of medical information in Alzheimer's disease after differential outcomes training.
    PLoS One. 2020;15:e0231578.
    PubMed     Abstract available


  107. KANG MW, Park S, Lee S, Lee Y, et al
    Glomerular hyperfiltration is associated with dementia: A nationwide population-based study.
    PLoS One. 2020;15:e0228361.
    PubMed     Abstract available


  108. BURES J, Kvetina J, Radochova V, Tacheci I, et al
    The pharmacokinetic parameters and the effect of a single and repeated doses of memantine on gastric myoelectric activity in experimental pigs.
    PLoS One. 2020;15:e0227781.
    PubMed     Abstract available


  109. LIMBAD C, Oron TR, Alimirah F, Davalos AR, et al
    Astrocyte senescence promotes glutamate toxicity in cortical neurons.
    PLoS One. 2020;15:e0227887.
    PubMed     Abstract available


  110. ROMERO-ROSALES BL, Tamez-Pena JG, Nicolini H, Moreno-Trevino MG, et al
    Improving predictive models for Alzheimer's disease using GWAS data by incorporating misclassified samples modeling.
    PLoS One. 2020;15:e0232103.
    PubMed     Abstract available


  111. MUELLER KD, Norton D, Koscik RL, Morris MC, et al
    Self-reported health behaviors and longitudinal cognitive performance in late middle age: Results from the Wisconsin Registry for Alzheimer's Prevention.
    PLoS One. 2020;15:e0221985.
    PubMed     Abstract available


  112. BEACH TG, Adler CH, Zhang N, Serrano GE, et al
    Severe hyposmia distinguishes neuropathologically confirmed dementia with Lewy bodies from Alzheimer's disease dementia.
    PLoS One. 2020;15:e0231720.
    PubMed     Abstract available


  113. KIM JO, Lee SJ, Pyo JS
    Effect of acetylcholinesterase inhibitors on post-stroke cognitive impairment and vascular dementia: A meta-analysis.
    PLoS One. 2020;15:e0227820.
    PubMed     Abstract available


  114. ICHINOSE T, Murasawa H, Ishijima T, Okada S, et al
    Tyr-Trp administration facilitates brain norepinephrine metabolism and ameliorates a short-term memory deficit in a mouse model of Alzheimer's disease.
    PLoS One. 2020;15:e0232233.
    PubMed     Abstract available


  115. LARGENT EA, Harkins K, van Dyck CH, Hachey S, et al
    Cognitively unimpaired adults' reactions to disclosure of amyloid PET scan results.
    PLoS One. 2020;15:e0229137.
    PubMed     Abstract available


  116. HIN N, Newman M, Kaslin J, Douek AM, et al
    Accelerated brain aging towards transcriptional inversion in a zebrafish model of the K115fs mutation of human PSEN2.
    PLoS One. 2020;15:e0227258.
    PubMed     Abstract available


  117. SOTO-MERCADO V, Mendivil-Perez M, Velez-Pardo C, Lopera F, et al
    Cholinergic-like neurons carrying PSEN1 E280A mutation from familial Alzheimer's disease reveal intraneuronal sAPPbeta fragments accumulation, hyperphosphorylation of TAU, oxidative stress, apoptosis and Ca2+ dysregulation: Therapeutic implications.
    PLoS One. 2020;15:e0221669.
    PubMed     Abstract available


  118. TSAI CW, Tsai CF, Lin KH, Chen WJ, et al
    An investigation of the correlation between the S-glutathionylated GAPDH levels in blood and Alzheimer's disease progression.
    PLoS One. 2020;15:e0233289.
    PubMed     Abstract available


  119. SEKINE T, Buck A, Delso G, Kemp B, et al
    The impact of atlas-based MR attenuation correction on the diagnosis of FDG-PET/MR for Alzheimer's diseases- A simulation study combining multi-center data and ADNI-data.
    PLoS One. 2020;15:e0233886.
    PubMed     Abstract available


  120. PINEDA AM, Ramos FM, Betting LE, Campanharo ASLO, et al
    Quantile graphs for EEG-based diagnosis of Alzheimer's disease.
    PLoS One. 2020;15:e0231169.
    PubMed     Abstract available


  121. JONESCO DS, Karsdal MA, Henriksen K
    The CNS-specific proteoglycan, brevican, and its ADAMTS4-cleaved fragment show differential serological levels in Alzheimer's disease, other types of dementia and non-demented controls: A cross-sectional study.
    PLoS One. 2020;15:e0234632.
    PubMed     Abstract available


  122. XIE L, Varathan P, Nho K, Saykin AJ, et al
    Identification of functionally connected multi-omic biomarkers for Alzheimer's disease using modularity-constrained Lasso.
    PLoS One. 2020;15:e0234748.
    PubMed     Abstract available


  123. KIM B, Shin J, Kim Y, Choi JH, et al
    Destruction of ERP responses to deviance in an auditory oddball paradigm in amyloid infusion mice with memory deficits.
    PLoS One. 2020;15:e0230277.
    PubMed     Abstract available


  124. NEDDENS J, Daurer M, Flunkert S, Beutl K, et al
    Correlation of pyroglutamate amyloid beta and ptau Ser202/Thr205 levels in Alzheimer's disease and related murine models.
    PLoS One. 2020;15:e0235543.
    PubMed     Abstract available


  125. OVEISGHARAN S, Dawe RJ, Leurgans SE, Yu L, et al
    Total daily physical activity, brain pathologies, and parkinsonism in older adults.
    PLoS One. 2020;15:e0232404.
    PubMed     Abstract available


  126. CAMPOS CR, Kemble AM, Niewoehner J, Freskgard PO, et al
    Brain Shuttle Neprilysin reduces central Amyloid-beta levels.
    PLoS One. 2020;15:e0229850.
    PubMed     Abstract available


  127. FENG X, Guo J, Sigmon HC, Sloan RP, et al
    Brain regions vulnerable and resistant to aging without Alzheimer's disease.
    PLoS One. 2020;15:e0234255.
    PubMed     Abstract available


  128. BELTRAN JF, Wahba BM, Hose N, Shasha D, et al
    Inexpensive, non-invasive biomarkers predict Alzheimer transition using machine learning analysis of the Alzheimer's Disease Neuroimaging (ADNI) database.
    PLoS One. 2020;15:e0235663.
    PubMed     Abstract available


  129. TANAKA N, Okuda M, Nishigaki T, Tsuchiya N, et al
    Development of a brain-permeable peptide nanofiber that prevents aggregation of Alzheimer pathogenic proteins.
    PLoS One. 2020;15:e0235979.
    PubMed     Abstract available


  130. ASANAD S, Fantini M, Sultan W, Nassisi M, et al
    Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline.
    PLoS One. 2020;15:e0232785.
    PubMed     Abstract available


  131. JEONG J, Park HJ, Mun BR, Jang JK, et al
    JBPOS0101 regulates amyloid beta, tau, and glial cells in an Alzheimer's disease model.
    PLoS One. 2020;15:e0237153.
    PubMed     Abstract available


  132. MAVILIO A, Sisto D, Prete F, Guadalupi V, et al
    RE-PERG in early-onset Alzheimer's disease: A double-blind, electrophysiological pilot study.
    PLoS One. 2020;15:e0236568.
    PubMed     Abstract available


  133. SOS KE, Mayer MI, Takacs VT, Major A, et al
    Amyloid beta induces interneuron-specific changes in the hippocampus of APPNL-F mice.
    PLoS One. 2020;15:e0233700.
    PubMed     Abstract available


  134. DATE Y, Sugiyama D, Tabuchi H, Saito N, et al
    The utility of simple questions to evaluate cognitive impairment.
    PLoS One. 2020;15:e0233225.
    PubMed     Abstract available


  135. FALKENHAIN K, Ruiz-Uribe NE, Haft-Javaherian M, Ali M, et al
    A pilot study investigating the effects of voluntary exercise on capillary stalling and cerebral blood flow in the APP/PS1 mouse model of Alzheimer's disease.
    PLoS One. 2020;15:e0235691.
    PubMed     Abstract available


  136. CLARK RA, Nikolova N, McGeown WJ, Macdonald M, et al
    Eigenvector alignment: Assessing functional network changes in amnestic mild cognitive impairment and Alzheimer's disease.
    PLoS One. 2020;15:e0231294.
    PubMed     Abstract available


  137. LIU HC, Lin WC, Chiu MJ, Lu CH, et al
    Development of an assay of plasma neurofilament light chain utilizing immunomagnetic reduction technology.
    PLoS One. 2020;15:e0234519.
    PubMed     Abstract available


  138. MAES T, Mascaro C, Rotllant D, Lufino MMP, et al
    Modulation of KDM1A with vafidemstat rescues memory deficit and behavioral alterations.
    PLoS One. 2020;15:e0233468.
    PubMed     Abstract available


  139. ZHANG S, Yang F, Wang Z, Qian X, et al
    Poor oral health conditions and cognitive decline: Studies in humans and rats.
    PLoS One. 2020;15:e0234659.
    PubMed     Abstract available


  140. TACKENBERG C, Kulic L, Nitsch RM
    Familial Alzheimer's disease mutations at position 22 of the amyloid beta-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
    PLoS One. 2020;15:e0239584.
    PubMed     Abstract available


  141. COUGHLAN G, Puthusseryppady V, Lowry E, Gillings R, et al
    Test-retest reliability of spatial navigation in adults at-risk of Alzheimer's disease.
    PLoS One. 2020;15:e0239077.
    PubMed     Abstract available


  142. LOPEZ-DE-EGUILETA A, Lage C, Lopez-Garcia S, Pozueta A, et al
    Evaluation of choroidal thickness in prodromal Alzheimer's disease defined by amyloid PET.
    PLoS One. 2020;15:e0239484.
    PubMed     Abstract available


  143. WANG YY, Ma WW, Peng IF
    Screening of sleep assisting drug candidates with a Drosophila model.
    PLoS One. 2020;15:e0236318.
    PubMed     Abstract available


  144. BOUBAKRI A, Leri M, Bucciantini M, Najjaa H, et al
    Allium roseum L. extract inhibits amyloid beta aggregation and toxicity involved in Alzheimer's disease.
    PLoS One. 2020;15:e0223815.
    PubMed     Abstract available


  145. MITSUMORI R, Sakaguchi K, Shigemizu D, Mori T, et al
    Lower DNA methylation levels in CpG island shores of CR1, CLU, and PICALM in the blood of Japanese Alzheimer's disease patients.
    PLoS One. 2020;15:e0239196.
    PubMed     Abstract available


  146. RONCERO C, Nikelski J, Probst S, Fernandez A, et al
    The semantic storage loss score: An Algorithm for measuring an individual's level of semantic storage loss due to temporal lobe damage in neurodegenerative disease.
    PLoS One. 2020;15:e0235810.
    PubMed     Abstract available


  147. GUPTA A, Kennedy K, Perales-Puchalt J, Drew D, et al
    Mild-moderate CKD is not associated with cognitive impairment in older adults in the Alzheimer's Disease Neuroimaging Initiative cohort.
    PLoS One. 2020;15:e0239871.
    PubMed     Abstract available


  148. GAO Y, Sengupta A, Li M, Zu Z, et al
    Functional connectivity of white matter as a biomarker of cognitive decline in Alzheimer's disease.
    PLoS One. 2020;15:e0240513.
    PubMed     Abstract available


  149. C RC, Lukose B, Rani P
    G82S RAGE polymorphism influences amyloid-RAGE interactions relevant in Alzheimer's disease pathology.
    PLoS One. 2020;15:e0225487.
    PubMed     Abstract available


  150. KUEPER JK, Lizotte DJ, Montero-Odasso M, Speechley M, et al
    Cognition and motor function: The gait and cognition pooled index.
    PLoS One. 2020;15:e0238690.
    PubMed     Abstract available


  151. YAO T, Sweeney E, Nagorski J, Shulman JM, et al
    Quantifying cognitive resilience in Alzheimer's Disease: The Alzheimer's Disease Cognitive Resilience Score.
    PLoS One. 2020;15:e0241707.
    PubMed     Abstract available


  152. YOKOSAWA K, Kimura K, Takase R, Murakami Y, et al
    Functional decline of the precuneus associated with mild cognitive impairment: Magnetoencephalographic observations.
    PLoS One. 2020;15:e0239577.
    PubMed     Abstract available


  153. AHMED S, Kim BC, Lee KH, Jung HY, et al
    Ensemble of ROI-based convolutional neural network classifiers for staging the Alzheimer disease spectrum from magnetic resonance imaging.
    PLoS One. 2020;15:e0242712.
    PubMed     Abstract available


  154. SEDGHIZADEH MJ, Hojjati H, Ezzatdoost K, Aghajan H, et al
    Olfactory response as a marker for Alzheimer's disease: Evidence from perceptual and frontal lobe oscillation coherence deficit.
    PLoS One. 2020;15:e0243535.
    PubMed     Abstract available


  155. OKUDA M, Fujita Y, Takada-Takatori Y, Sugimoto H, et al
    Aromatherapy improves cognitive dysfunction in senescence-accelerated mouse prone 8 by reducing the level of amyloid beta and tau phosphorylation.
    PLoS One. 2020;15:e0240378.
    PubMed     Abstract available


  156. GUYON A, Rousseau J, Lamothe G, Tremblay JP, et al
    The protective mutation A673T in amyloid precursor protein gene decreases Abeta peptides production for 14 forms of Familial Alzheimer's Disease in SH-SY5Y cells.
    PLoS One. 2020;15:e0237122.
    PubMed     Abstract available


  157. KIM D, Lee JH, Kim HY, Shin J, et al
    Fluorescent indolizine derivative YI-13 detects amyloid-beta monomers, dimers, and plaques in the brain of 5XFAD Alzheimer transgenic mouse model.
    PLoS One. 2020;15:e0243041.
    PubMed     Abstract available


  158. DENG Y, Wu S, Fan H
    Genome-wide pathway-based quantitative multiple phenotypes analysis.
    PLoS One. 2020;15:e0240910.
    PubMed     Abstract available


  159. LI QS, Tian C, Hinds D, Seabrook GR, et al
    The association of clinical phenotypes to known AD/FTD genetic risk loci and their inter-relationship.
    PLoS One. 2020;15:e0241552.
    PubMed     Abstract available


  160. MENTINK LJ, Thomas J, Melis RJF, Olde Rikkert MGM, et al
    Home-EEG assessment of possible compensatory mechanisms for sleep disruption in highly irregular shift workers - The ANCHOR study.
    PLoS One. 2020;15:e0237622.
    PubMed     Abstract available


  161. GREEN EH, Kikis EA
    Determining the effects of nanoparticulate air pollution on proteostasis in Caenorhabditis elegans.
    PLoS One. 2020;15:e0243419.
    PubMed     Abstract available


  162. BORGSTEDT L, Blobner M, Musiol M, Bratke S, et al
    Neurotoxicity of different amyloid beta subspecies in mice and their interaction with isoflurane anaesthesia.
    PLoS One. 2020;15:e0242989.
    PubMed     Abstract available


    January 2019
  163. POTASHKIN JA, Bottero V, Santiago JA, Quinn JP, et al
    Computational identification of key genes that may regulate gene expression reprogramming in Alzheimer's patients.
    PLoS One. 2019;14:e0222921.
    PubMed     Abstract available


  164. LIU Z, Wang W, Huang T, Wang C, et al
    CH(II), a cerebroprotein hydrolysate, exhibits potential neuro-protective effect on Alzheimer's disease.
    PLoS One. 2019;14:e0222757.
    PubMed     Abstract available


  165. GILLIGAN TM, Sibilia F, Farrell D, Lyons D, et al
    No relationship between fornix and cingulum degradation and within-network decreases in functional connectivity in prodromal Alzheimer's disease.
    PLoS One. 2019;14:e0222977.
    PubMed     Abstract available


  166. SMILNAK GJ, Deans JR, Doraiswamy PM, Stinnett S, et al
    Comorbidity of age-related macular degeneration with Alzheimer's disease: A histopathologic case-control study.
    PLoS One. 2019;14:e0223199.
    PubMed     Abstract available


  167. JOSEPH DJ, Liu C, Peng J, Liang G, et al
    Isoflurane mediated neuropathological and cognitive impairments in the triple transgenic Alzheimer's mouse model are associated with hippocampal synaptic deficits in an age-dependent manner.
    PLoS One. 2019;14:e0223509.
    PubMed     Abstract available


  168. SUDO FK, de Souza AS, Drummond C, Assuncao N, et al
    Inter-method and anatomical correlates of episodic memory tests in the Alzheimer's Disease spectrum.
    PLoS One. 2019;14:e0223731.
    PubMed     Abstract available


  169. MUNOZ-CABRERA JM, Sandoval-Hernandez AG, Nino A, Baez T, et al
    Bexarotene therapy ameliorates behavioral deficits and induces functional and molecular changes in very-old Triple Transgenic Mice model of Alzheimer s disease.
    PLoS One. 2019;14:e0223578.
    PubMed     Abstract available


  170. GUPTA Y, Lee KH, Choi KY, Lee JJ, et al
    Early diagnosis of Alzheimer's disease using combined features from voxel-based morphometry and cortical, subcortical, and hippocampus regions of MRI T1 brain images.
    PLoS One. 2019;14:e0222446.
    PubMed     Abstract available


  171. PARKER TD, Cash DM, Lane CAS, Lu K, et al
    Hippocampal subfield volumes and pre-clinical Alzheimer's disease in 408 cognitively normal adults born in 1946.
    PLoS One. 2019;14:e0224030.
    PubMed     Abstract available


  172. JANG HD, Park JS, Kim DW, Han K, et al
    Relationship between dementia and ankylosing spondylitis: A nationwide, population-based, retrospective longitudinal cohort study.
    PLoS One. 2019;14:e0210335.
    PubMed     Abstract available


  173. GOFRIT ON, Klein BY, Cohen IR, Ben-Hur T, et al
    Bacillus Calmette-Guerin (BCG) therapy lowers the incidence of Alzheimer's disease in bladder cancer patients.
    PLoS One. 2019;14:e0224433.
    PubMed     Abstract available


  174. YOUSSIF KA, Haggag EG, Elshamy AM, Rabeh MA, et al
    Anti-Alzheimer potential, metabolomic profiling and molecular docking of green synthesized silver nanoparticles of Lampranthus coccineus and Malephora lutea aqueous extracts.
    PLoS One. 2019;14:e0223781.
    PubMed     Abstract available


  175. KIM JI, Kang BH
    Decreased retinal thickness in patients with Alzheimer's disease is correlated with disease severity.
    PLoS One. 2019;14:e0224180.
    PubMed     Abstract available


  176. DEMARSHALL C, Oh E, Kheirkhah R, Sieber F, et al
    Detection of early-stage Alzheimer's pathology using blood-based autoantibody biomarkers in elderly hip fracture repair patients.
    PLoS One. 2019;14:e0225178.
    PubMed     Abstract available


  177. YANEZ LOPEZ M, Pardon MC, Baiker K, Prior M, et al
    Myoinositol CEST signal in animals with increased Iba-1 levels in response to an inflammatory challenge-Preliminary findings.
    PLoS One. 2019;14:e0212002.
    PubMed     Abstract available


  178. HUANG Q, Sun D, Zubair Hussain M, Liu Y, et al
    HEWL interacts with dissipated oleic acid micelles, and decreases oleic acid cytotoxicity.
    PLoS One. 2019;14:e0212648.
    PubMed     Abstract available


  179. CHO SJ, Yun SM, Jo C, Jeong J, et al
    Altered expression of Notch1 in Alzheimer's disease.
    PLoS One. 2019;14:e0224941.
    PubMed     Abstract available


  180. PANAYIOTOU E, Fella E, Andreou S, Papacharalambous R, et al
    C5aR agonist enhances phagocytosis of fibrillar and non-fibrillar Abeta amyloid and preserves memory in a mouse model of familial Alzheimer's disease.
    PLoS One. 2019;14:e0225417.
    PubMed     Abstract available


  181. PUNJABI A, Martersteck A, Wang Y, Parrish TB, et al
    Neuroimaging modality fusion in Alzheimer's classification using convolutional neural networks.
    PLoS One. 2019;14:e0225759.
    PubMed     Abstract available


  182. SILZER T, Barber R, Sun J, Pathak G, et al
    Circulating mitochondrial DNA: New indices of type 2 diabetes-related cognitive impairment in Mexican Americans.
    PLoS One. 2019;14:e0213527.
    PubMed     Abstract available


  183. PARK JE, Yun J, Kim SJ, Shim WH, et al
    Intra-individual correlations between quantitative THK-5351 PET and MRI-derived cortical volume in Alzheimer's disease differ according to disease severity and amyloid positivity.
    PLoS One. 2019;14:e0226265.
    PubMed     Abstract available


  184. OH AJ, Amore G, Sultan W, Asanad S, et al
    Pupillometry evaluation of melanopsin retinal ganglion cell function and sleep-wake activity in pre-symptomatic Alzheimer's disease.
    PLoS One. 2019;14:e0226197.
    PubMed     Abstract available


  185. TOKUOKA SM, Kita Y, Shimizu T, Oda Y, et al
    Isobaric mass tagging and triple quadrupole mass spectrometry to determine lipid biomarker candidates for Alzheimer's disease.
    PLoS One. 2019;14:e0226073.
    PubMed     Abstract available


  186. ELMER BM, Swanson KA, Bangari DS, Piepenhagen PA, et al
    Gene delivery of a modified antibody to Abeta reduces progression of murine Alzheimer's disease.
    PLoS One. 2019;14:e0226245.
    PubMed     Abstract available


  187. OZSAHIN I, Sekeroglu B, Mok GSP
    The use of back propagation neural networks and 18F-Florbetapir PET for early detection of Alzheimer's disease using Alzheimer's Disease Neuroimaging Initiative database.
    PLoS One. 2019;14:e0226577.
    PubMed     Abstract available


  188. IVASHKO-PACHIMA Y, Maor-Nof M, Gozes I
    NAP (davunetide) preferential interaction with dynamic 3-repeat Tau explains differential protection in selected tauopathies.
    PLoS One. 2019;14:e0213666.
    PubMed     Abstract available


  189. MCGRATH ER, Himali JJ, Levy D, Conner SC, et al
    Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study.
    PLoS One. 2019;14:e0213321.
    PubMed     Abstract available


  190. GRANT MKO, Handoko M, Rozga M, Brinkmalm G, et al
    Human cerebrospinal fluid 6E10-immunoreactive protein species contain amyloid precursor protein fragments.
    PLoS One. 2019;14:e0212815.
    PubMed     Abstract available


  191. DING X, Charnigo RJ, Schmitt FA, Kryscio RJ, et al
    Evaluating trajectories of episodic memory in normal cognition and mild cognitive impairment: Results from ADNI.
    PLoS One. 2019;14:e0212435.
    PubMed     Abstract available


  192. MONACO A, Amoroso N, Bellantuono L, Lella E, et al
    Shannon entropy approach reveals relevant genes in Alzheimer's disease.
    PLoS One. 2019;14:e0226190.
    PubMed     Abstract available


  193. ROYALL DR, Palmer RF
    Selection for depression-specific dementia cases with replication in two cohorts.
    PLoS One. 2019;14:e0216413.
    PubMed     Abstract available


  194. PATIL DN, Patil SA, Sistla S, Jadhav JP, et al
    Comparative biophysical characterization: A screening tool for acetylcholinesterase inhibitors.
    PLoS One. 2019;14:e0215291.
    PubMed     Abstract available


  195. ESQUERDA-CANALS G, Marti-Clua J, Villegas S
    Pharmacokinetic parameters and mechanism of action of an efficient anti-Abeta single chain antibody fragment.
    PLoS One. 2019;14:e0217793.
    PubMed     Abstract available


  196. SINNIGE T, Ciryam P, Casford S, Dobson CM, et al
    Expression of the amyloid-beta peptide in a single pair of C. elegans sensory neurons modulates the associated behavioural response.
    PLoS One. 2019;14:e0217746.
    PubMed     Abstract available


  197. HUANG YY, Chiu MJ, Yen RF, Tsai CL, et al
    An one-pot two-step automated synthesis of [18F]T807 injection, its biodistribution in mice and monkeys, and a preliminary study in humans.
    PLoS One. 2019;14:e0217384.
    PubMed     Abstract available


  198. ETO M, Hashimoto T, Shimizu T, Iwatsubo T, et al
    Characterization of the unique In Vitro effects of unsaturated fatty acids on the formation of amyloid beta fibrils.
    PLoS One. 2019;14:e0219465.
    PubMed     Abstract available


  199. CHEN JL, Moss WN, Spencer A, Zhang P, et al
    The RNA encoding the microtubule-associated protein tau has extensive structure that affects its biology.
    PLoS One. 2019;14:e0219210.
    PubMed     Abstract available


  200. HUANG CN, Wang CJ, Lin CL, Yen AT, et al
    Abelmoschus esculentus subfractions attenuate beta amyloid-induced neuron apoptosis by regulating DPP-4 with improving insulin resistance signals.
    PLoS One. 2019;14:e0217400.
    PubMed     Abstract available


  201. HOFFMAN JD, Yanckello LM, Chlipala G, Hammond TC, et al
    Dietary inulin alters the gut microbiome, enhances systemic metabolism and reduces neuroinflammation in an APOE4 mouse model.
    PLoS One. 2019;14:e0221828.
    PubMed     Abstract available


  202. MCAVOY KM, Rajamohamed Sait H, Marsh G, Peterson M, et al
    Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.
    PLoS One. 2019;14:e0220125.
    PubMed     Abstract available


  203. BUCHMAN AS, Yu L, Petyuk VA, Gaiteri C, et al
    Cognition may link cortical IGFBP5 levels with motor function in older adults.
    PLoS One. 2019;14:e0220968.
    PubMed     Abstract available


  204. HVIDSTEN L, Engedal K, Selbaek G, Wyller TB, et al
    Quality of life of family carers of persons with young-onset dementia: A Nordic two-year observational multicenter study.
    PLoS One. 2019;14:e0219859.
    PubMed     Abstract available


  205. UEKI M, Fujii M, Tamiya G
    Quick assessment for systematic test statistic inflation/deflation due to null model misspecifications in genome-wide environment interaction studies.
    PLoS One. 2019;14:e0219825.
    PubMed     Abstract available


  206. REES JMB, Wood AM, Dudbridge F, Burgess S, et al
    Robust methods in Mendelian randomization via penalization of heterogeneous causal estimates.
    PLoS One. 2019;14:e0222362.
    PubMed     Abstract available


  207. CHAGANTI S, Welty VF, Taylor W, Albert K, et al
    Discovering novel disease comorbidities using electronic medical records.
    PLoS One. 2019;14:e0225495.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: